Akebia Therapeutics (AKBA) Inventory Average (2019 - 2026)

Akebia Therapeutics (AKBA) has 8 years of Inventory Average data on file, last reported at $14.3 million in Q1 2026.

• On a quarterly basis, Inventory Average fell 20.48% year-over-year to $14.3 million in Q1 2026; TTM through Mar 2026 was $14.3 million, a 20.48% decrease from a year earlier, with the FY2025 full-year figure at $15.9 million, changed 0.25% from the prior year.
• Inventory Average for Q1 2026 stood at $14.3 million, down from $17.1 million in the prior quarter.
• Over the last five years, Inventory Average for AKBA reached as high as $42.7 million in Q3 2022 and fell as low as $14.3 million in Q1 2026.
• Historically, Inventory Average has averaged $23.8 million across 5 years, with a median of $20.6 million in 2024.
• Across the five-year window, Inventory Average sank 53.96% in 2023 and advanced 19.58% in 2024, its largest moves.
• Year by year, Inventory Average stood at $33.4 million in 2022, then sank by 48.91% to $17.1 million in 2023, then climbed by 7.63% to $18.4 million in 2024, then declined by 6.76% to $17.1 million in 2025, then fell by 16.49% to $14.3 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $14.3 million in Q1 2026, $17.1 million in Q4 2025, and $17.7 million in Q3 2025.